-
1
-
-
33645299075
-
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe
-
Ljungman, P., Urbano-Ispizua, A., Cavazzana-Calvo, M., Dermirer, T., Dini, G. and Einsele, H. (2006) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant, 37, pp. 439-449.
-
(2006)
Bone Marrow Transplant
, vol.37
, pp. 439-449
-
-
Ljungman, P.1
Urbano-Ispizua, A.2
Cavazzana-Calvo, M.3
Dermirer, T.4
Dini, G.5
Einsele, H.6
-
2
-
-
0027404777
-
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial
-
Linch, D. C., Winfield, D., Goldstone, A. H., Moir, D., Hancock, B. and McMillan, A. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial. Lancet, 341, pp. 1051-1054.
-
(1993)
Lancet
, vol.341
, pp. 1051-1054
-
-
Linch, D.C.1
Winfield, D.2
Goldstone, A.H.3
Moir, D.4
Hancock, B.5
McMillan, A.6
-
3
-
-
0037097044
-
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haematopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial
-
Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, M. and Haenel, M. (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haematopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial. Lancet, 359, pp. 2065-2071.
-
(2002)
Lancet
, vol.359
, pp. 2065-2071
-
-
Schmitz, N.1
Pfistner, B.2
Sextro, M.3
Sieber, M.4
Carella, M.5
Haenel, M.6
-
4
-
-
0027954426
-
Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy
-
Reece, D. E., Connors, J. M., Spinelli, J., Barnett, M. J., Fairey, R. N. and Klingermann, H. (1994) Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood, 83, pp. 1193-1199.
-
(1994)
Blood
, vol.83
, pp. 1193-1199
-
-
Reece, D.E.1
Connors, J.M.2
Spinelli, J.3
Barnett, M.J.4
Fairey, R.N.5
Klingermann, H.6
-
5
-
-
0028937428
-
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: Results in 85 patients with analysis of prognostic factors
-
Nademanee, A., O'Donnell, M. R., Snyder, D. S., Schmidt, G., Parker, P. and Stein, A. (1995) High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: Results in 85 patients with analysis of prognostic factors. Blood, 85, pp. 1381-1390.
-
(1995)
Blood
, vol.85
, pp. 1381-1390
-
-
Nademanee, A.1
O'Donnell, M.R.2
Snyder, D.S.3
Schmidt, G.4
Parker, P.5
Stein, A.6
-
6
-
-
0030942265
-
Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease
-
Yuen, A. R., Rosenberg, S. A., Hoppe, R. T., Halpern, J. and Horning, S. (1997) Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood, 89, pp. 814-822.
-
(1997)
Blood
, vol.89
, pp. 814-822
-
-
Yuen, A.R.1
Rosenberg, S.A.2
Hoppe, R.T.3
Halpern, J.4
Horning, S.5
-
7
-
-
0027534424
-
The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients
-
Chopra, R., McMillan, A. K., Linch, D. C., Yuklea, S., Taghipour, G. and Pearce, R. (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood, 81, pp. 1137-1145.
-
(1993)
Blood
, vol.81
, pp. 1137-1145
-
-
Chopra, R.1
McMillan, A.K.2
Linch, D.C.3
Yuklea, S.4
Taghipour, G.5
Pearce, R.6
-
8
-
-
17744384690
-
Autotransplantation for Hodgkin's disease in first relapse or second remission: A report from the Autologous Blood and Marrow Transplantation Registry (ABMTR)
-
Lazarus, H. M., Loberiza, F. R., Zhang, M. J., Armitage, J. O., Ballen, K. K. and Bashey, A. (2001) Autotransplantation for Hodgkin's disease in first relapse or second remission: A report from the Autologous Blood and Marrow Transplantation Registry (ABMTR). Bone Marrow Transplant, 27, pp. 387-396.
-
(2001)
Bone Marrow Transplant
, vol.27
, pp. 387-396
-
-
Lazarus, H.M.1
Loberiza, F.R.2
Zhang, M.J.3
Armitage, J.O.4
Ballen, K.K.5
Bashey, A.6
-
9
-
-
20944446433
-
Prognostic factors affecting long-term outcome after stem-cell transplantation in Hodgkin's lymphoma autografted after a first relapse
-
Sureda, A., Constans, M., Irondo, A., Arranz, R., Caballero, M. D. and Vidal, M. J. (2005) Prognostic factors affecting long-term outcome after stem-cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol, 16, pp. 625-633.
-
(2005)
Ann Oncol
, vol.16
, pp. 625-633
-
-
Sureda, A.1
Constans, M.2
Irondo, A.3
Arranz, R.4
Caballero, M.D.5
Vidal, M.J.6
-
10
-
-
0027409446
-
High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: Importance of disease status at transplant
-
Crump, M., Smith, A. M., Brandwein, J., Couture, F., Sherret, H. and Sutton, D. M. (1993) High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: Importance of disease status at transplant. J Clin Oncol, 11, p. 704.
-
(1993)
J Clin Oncol
, vol.11
, pp. 704
-
-
Crump, M.1
Smith, A.M.2
Brandwein, J.3
Couture, F.4
Sherret, H.5
Sutton, D.M.6
-
11
-
-
0027146193
-
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome
-
Rapoport, A. P., Rowe, J. M., Kouides, P. A., Duerst, R. A., Abboud, C. N. and Liesveld, J. L. (1993) One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome. J Clin Oncol, 11, pp. 2351-2361.
-
(1993)
J Clin Oncol
, vol.11
, pp. 2351-2361
-
-
Rapoport, A.P.1
Rowe, J.M.2
Kouides, P.A.3
Duerst, R.A.4
Abboud, C.N.5
Liesveld, J.L.6
-
12
-
-
0031967030
-
Favourable outcome of patients relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell transplantation at the time of maximal response to conventional salvage therapy (Dexa-BEAM)
-
Josting, A., Katay, I., Rueffer, U., Winter, S., Tesh, H. and Engert, A. (1998) Favourable outcome of patients relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell transplantation at the time of maximal response to conventional salvage therapy (Dexa-BEAM). Ann Oncol, 9, pp. 289-295.
-
(1998)
Ann Oncol
, vol.9
, pp. 289-295
-
-
Josting, A.1
Katay, I.2
Rueffer, U.3
Winter, S.4
Tesh, H.5
Engert, A.6
-
13
-
-
0034663188
-
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: A report from the German Hodgkin Lymphoma Study Group
-
Josting, A., Rueffer, U., Franklin, J., Sieber, M., Diehl, V. and Engert, A. (2000) Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: A report from the German Hodgkin Lymphoma Study Group. Blood, 96, pp. 1280-1286.
-
(2000)
Blood
, vol.96
, pp. 1280-1286
-
-
Josting, A.1
Rueffer, U.2
Franklin, J.3
Sieber, M.4
Diehl, V.5
Engert, A.6
-
14
-
-
2942536855
-
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma
-
Popat, U., Hosing, C., Saliba, R. M., Anderlini, P., van Besien, K. and Przepiorka, D. (2004) Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma. Bone Marrow Transplant, 33, pp. 1015-1023.
-
(2004)
Bone Marrow Transplant
, vol.33
, pp. 1015-1023
-
-
Popat, U.1
Hosing, C.2
Saliba, R.M.3
Anderlini, P.4
van Besien, K.5
Przepiorka, D.6
-
15
-
-
0036737680
-
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation
-
Bierman, P. J., Lynch, J. C., Bociek, R. G., Whalen, V. L., Kessinger, A. and Vose, J. M. (2002) The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation. Ann Oncol, 13, pp. 1370-1377.
-
(2002)
Ann Oncol
, vol.13
, pp. 1370-1377
-
-
Bierman, P.J.1
Lynch, J.C.2
Bociek, R.G.3
Whalen, V.L.4
Kessinger, A.5
Vose, J.M.6
-
16
-
-
0035281922
-
Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea Spanish Cooperative Group
-
Sureda, A., Arranz, R., Iriondo, A., Carreras, E., Lahuerta, J. J. and García-Conde, J. (2001) Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea Spanish Cooperative Group. J Clin Oncol, 19, pp. 1395-1404.
-
(2001)
J Clin Oncol
, vol.19
, pp. 1395-1404
-
-
Sureda, A.1
Arranz, R.2
Iriondo, A.3
Carreras, E.4
Lahuerta, J.J.5
García-Conde, J.6
-
17
-
-
0032887877
-
High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation
-
Sweetenham, J., Carella, A., Taghipour, G., Cunningham, D., Marcus, R. and Della Volpe, A. (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation. J Clin Oncol, 17, pp. 3101-3109.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3101-3109
-
-
Sweetenham, J.1
Carella, A.2
Taghipour, G.3
Cunningham, D.4
Marcus, R.5
Della Volpe, A.6
-
18
-
-
0033008436
-
Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the Autologous Blood and Marrow Transplantation Registry (ABMTR)
-
Lazarus, H. M., Rowlings, P. A., Zhang, M. J., Vose, J. M., Armitage, J. and Bierman, P. (1999) Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the Autologous Blood and Marrow Transplantation Registry (ABMTR). J Clin Oncol, 17, pp. 534-545.
-
(1999)
J Clin Oncol
, vol.17
, pp. 534-545
-
-
Lazarus, H.M.1
Rowlings, P.A.2
Zhang, M.J.3
Vose, J.M.4
Armitage, J.5
Bierman, P.6
-
19
-
-
0037767208
-
Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome
-
Constans, M., Sureda, A., Terol, M. J., Arranz, R., Caballero, M. D. and Irondo, A. (2003) Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome. Ann Oncol, 14, pp. 745-751.
-
(2003)
Ann Oncol
, vol.14
, pp. 745-751
-
-
Constans, M.1
Sureda, A.2
Terol, M.J.3
Arranz, R.4
Caballero, M.D.5
Irondo, A.6
-
20
-
-
0037080278
-
Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: Results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial
-
Fermé, C., Mournier, N., Diviné M., Brice, P., Stamatoullas, A. and Reman, O. (2002) Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: Results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. J Clin Oncol, 20, pp. 467-475.
-
(2002)
J Clin Oncol
, vol.20
, pp. 467-475
-
-
Fermé, C.1
Mournier, N.2
Diviné, M.3
Brice, P.4
Stamatoullas, A.5
Reman, O.6
-
21
-
-
0032548107
-
A prognostic score for advanced Hodgkin's disease
-
Hasenclever, D. and Diehl, V. (1998) A prognostic score for advanced Hodgkin's disease. N Eng J Med, 339, pp. 1506-1514.
-
(1998)
N Eng J Med
, vol.339
, pp. 1506-1514
-
-
Hasenclever, D.1
Diehl, V.2
-
22
-
-
0030938978
-
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices
-
Horning, S. J., Chao, N. J., Negrin, R. S., Hoppe, R. and Long, G. (1997) High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices. Blood, 89, pp. 801-813.
-
(1997)
Blood
, vol.89
, pp. 801-813
-
-
Horning, S.J.1
Chao, N.J.2
Negrin, R.S.3
Hoppe, R.4
Long, G.5
-
23
-
-
0034799456
-
Hodgkin's disease: Prognostic role of gallium scintigraphy after chemotherapy
-
Brenot-Rossi, I., Bouabdallah, R., Stefano, D Di, Bardou, V. J., Stoppa, A. M. and Camerlo, J. (2001) Hodgkin's disease: Prognostic role of gallium scintigraphy after chemotherapy. Eur J Nucl Med, 28, pp. 1482-1488.
-
(2001)
Eur J Nucl Med
, vol.28
, pp. 1482-1488
-
-
Brenot-Rossi, I.1
Bouabdallah, R.2
Stefano, D.3
Di Bardou, V.J.4
Stoppa, A.M.5
Camerlo, J.6
-
24
-
-
0033955726
-
Clinical relevance of 67-gallium scintigraphy in lymphoma before and after chemotherapy
-
Delcambre, C., Reman, O., Henry-Amar, M., Peny, Am, Macro, M. and Cheze, S. (2000) Clinical relevance of 67-gallium scintigraphy in lymphoma before and after chemotherapy. Eur J Nucl Med, 27, pp. 176-184.
-
(2000)
Eur J Nucl Med
, vol.27
, pp. 176-184
-
-
Delcambre, C.1
Reman, O.2
Henry-Amar, M.3
Peny Am Macro, M.4
Cheze, S.5
|